8:00 AM

Abbott Laboratories
John B. Thomas, Divisional VP, IR

GPC Biotech AG
Mirko Scherer, CFO

8:35 AM

WellPoint Health Networks Inc.
David Colby, EVP & CFO

SCIOS, Inc.
David Gryska, CFO

9:10 AM

RightCHOICE John O' Rourke

Aradigm Corporation
Rick Thompson, President, CEO & Chairman

9:45 AM

Genzyme General
James Geraghty, SVP Intl. Dev.

Digene Corporation
Charles M. Fleischman, President

10:20 AM

Laboratory Corporation of America
Bradford T. Smith, EVP Public Affairs

MorphoSys AG
Simon Moroney, CEO

10:55 AM

Regeneron Pharmaceuticals, Inc.
Murray A. Goldberg, SVP, Finance Admin. & CEO

Genzyme Molecular Oncology
Gail Maderis, President

11:30 AM

Panel Discussion Renal/Dialysis
Professor Claude Jacobs
Professor Anders Alvestrand
Bernard Canaud, M.D.

Vernalis Group plc
Robert Mansfield, CEO

12:30 PM

Lunch - Medtech & Health Services Analyst Presentations

14:00 PM

Sepracor
Jonae Barnes, VP IR & Corp. Comms.

Bruker Daltonics, Inc.
Michael Willett, Investor Relations Officer

14:35 PM

Variagenics
Rick Shea, CFO

15:10 PM

Smith & Nephew plc
Chris O'Donnell, Chief Executive

Novuspharma SpA
Silvano Spinelli, CEO

15:45 PM

Oxford GlycoSciences plc
Stephen Parker, CFO

Stressgen Biotechnologies Corp.
Donald Tartre, VP & CFO

16:20 PM

Shire Pharmaceuticals
Angus Russell, CFO

Karo Bio AB*
Per Otteskog, SVP Investor Relations

16:55 PM

Antisoma plc
Glyn Edwards, CEO

Axcan PharmaceuticalsLeon
Gosselin, President & CEO

17:30 PM

Genmab
Lisa Drakeman, CEO

Bioject Inc.
Mike Temple, EVP & General Manager